| (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:1313655 | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TTK mRNA | CTD | PMID:22079256 |
| 17beta-estradiol | increases expression | ISO | RGD:1313655 | 6480464 | Estradiol results in increased expression of TTK mRNA | CTD | PMID:18310284 more ... |
| 17beta-estradiol | increases expression | ISO | RGD:1313655 | 6480464 | Estradiol results in increased expression of TTK mRNA | CTD | PMID:19167446 PMID:20106945 |
| 17beta-estradiol | increases expression | ISO | RGD:1313655 | 6480464 | Estradiol results in increased expression of TTK mRNA | CTD | PMID:20106945 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1313655 | 6480464 | Tetrachlorodibenzodioxin affects the expression of TTK mRNA | CTD | PMID:22298810 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1313655 | 6480464 | Tetrachlorodibenzodioxin affects the expression of TTK mRNA | CTD | PMID:22298810 PMID:22574217 |
| 2-methylcholine | affects expression | ISO | RGD:1313655 | 6480464 | beta-methylcholine affects the expression of TTK mRNA | CTD | PMID:21179406 |
| 3-methylcholanthrene | increases expression | ISO | RGD:1313656 | 6480464 | Methylcholanthrene results in increased expression of TTK mRNA | CTD | PMID:20713471 |
| 5-azacytidine | multiple interactions | ISO | RGD:1313655 | 6480464 | [Azacitidine co-treated with Thalidomide] affects the expression of TTK mRNA | CTD | PMID:18720364 |
| aflatoxin B1 | affects expression | ISO | RGD:1313655 | 6480464 | Aflatoxin B1 affects the expression of TTK protein | CTD | PMID:20106945 |
| benzo[a]pyrene | decreases expression | ISO | RGD:1313655 | 6480464 | Benzo(a)pyrene results in decreased expression of TTK mRNA | CTD | PMID:20064835 |
| benzo[a]pyrene | decreases expression | ISO | RGD:1313655 | 6480464 | Benzo(a)pyrene results in decreased expression of TTK mRNA | CTD | PMID:16120219 more ... |
| benzo[a]pyrene | decreases expression | ISO | RGD:1313655 | 6480464 | Benzo(a)pyrene results in decreased expression of TTK mRNA | CTD | PMID:20064835 PMID:21632981 |
| benzo[a]pyrene | decreases expression | ISO | RGD:1313656 | 6480464 | Benzo(a)pyrene results in decreased expression of TTK mRNA | CTD | PMID:19770486 |
| bis(2-chloroethyl) sulfide | decreases expression | ISO | RGD:1313656 | 6480464 | Mustard Gas results in decreased expression of TTK mRNA | CTD | PMID:18955075 |
| bis(2-chloroethyl) sulfide | increases expression | ISO | RGD:1313656 | 6480464 | Mustard Gas results in increased expression of TTK mRNA | CTD | PMID:15674844 |
| calcitriol | multiple interactions | ISO | RGD:1313655 | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of TTK mRNA | CTD | PMID:21592394 |
| calcitriol | decreases expression | ISO | RGD:1313655 | 6480464 | Calcitriol results in decreased expression of TTK mRNA | CTD | PMID:21592394 |
| cefaloridine | decreases expression | EXP | | 6480464 | Cephaloridine results in decreased expression of TTK mRNA | CTD | PMID:18500788 |
| choline | multiple interactions | ISO | RGD:1313656 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of TTK gene | CTD | PMID:20938992 |
| cisplatin | multiple interactions | ISO | RGD:1313655 | 6480464 | Cisplatin promotes the reaction [Piroxicam results in decreased expression of TTK mRNA] | CTD | PMID:21858171 |
| cisplatin | decreases expression | EXP | | 6480464 | Cisplatin results in decreased expression of TTK mRNA | CTD | PMID:22023808 |
| cisplatin | increases expression | ISO | RGD:1313656 | 6480464 | Cisplatin results in increased expression of TTK mRNA | CTD | PMID:21151649 |
| clofibrate | multiple interactions | ISO | RGD:1313656 | 6480464 | PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of TTK mRNA] | CTD | PMID:17585979 |
| copper(2+) sulfate | decreases expression | ISO | RGD:1313655 | 6480464 | Copper Sulfate results in decreased expression of TTK mRNA | CTD | PMID:19549813 |
| coumestrol | multiple interactions | ISO | RGD:1313655 | 6480464 | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TTK mRNA; more ... | CTD | PMID:19167446 |
| coumestrol | increases expression | ISO | RGD:1313655 | 6480464 | Coumestrol results in increased expression of TTK mRNA | CTD | PMID:19167446 |
| cyclosporin A | decreases expression | ISO | RGD:1313655 | 6480464 | Cyclosporine results in decreased expression of TTK mRNA | CTD | PMID:20106945 |
| cyclosporin A | decreases expression | ISO | RGD:1313655 | 6480464 | Cyclosporine results in decreased expression of TTK mRNA | CTD | PMID:20106945 PMID:21632981 |
| dasatinib (anhydrous) | decreases expression | ISO | RGD:1313655 | 6480464 | dasatinib results in decreased expression of TTK mRNA | CTD | PMID:20579391 |
| dibutyl phthalate | decreases expression | ISO | RGD:1313656 | 6480464 | Dibutyl Phthalate results in decreased expression of TTK mRNA | CTD | PMID:21266533 |
| dibutyl phthalate | decreases expression | ISO | RGD:1313656 | 6480464 | Dibutyl Phthalate results in decreased expression of TTK mRNA | CTD | PMID:17361019 PMID:21266533 |
| doxorubicin | affects response to substance | ISO | RGD:1313655 | 6480464 | TTK protein affects the susceptibility to Doxorubicin | CTD | PMID:16217747 |
| etoposide | decreases expression | ISO | RGD:1313655 | 6480464 | Etoposide results in decreased expression of TTK mRNA | CTD | PMID:16120219 |
| folic acid | multiple interactions | ISO | RGD:1313656 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of TTK gene | CTD | PMID:20938992 |
| fulvestrant | multiple interactions | ISO | RGD:1313655 | 6480464 | [fulvestrant co-treated with Sirolimus] results in decreased expression of TTK mRNA | CTD | PMID:19016759 |
| fulvestrant | decreases expression | ISO | RGD:1313655 | 6480464 | fulvestrant results in decreased expression of TTK mRNA | CTD | PMID:19016759 |
| genistein | affects expression | ISO | RGD:1313655 | 6480464 | Genistein affects the expression of TTK mRNA | CTD | PMID:18847459 |
| kojic acid | decreases expression | ISO | RGD:1313655 | 6480464 | kojic acid results in decreased expression of TTK mRNA | CTD | PMID:16595896 |
| L-methionine | multiple interactions | ISO | RGD:1313656 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of TTK gene | CTD | PMID:20938992 |
| lithium atom | increases expression | EXP | | 6480464 | Lithium results in increased expression of TTK mRNA | CTD | PMID:21711903 |
| lucanthone | decreases expression | ISO | RGD:1313655 | 6480464 | Lucanthone results in decreased expression of TTK mRNA | CTD | PMID:21148553 |
| N-nitrosodiethylamine | increases expression | ISO | RGD:1313656 | 6480464 | Diethylnitrosamine results in increased expression of TTK mRNA | CTD | PMID:17854601 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:1313656 | 6480464 | RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of TTK mRNA] | CTD | PMID:17854601 |
| paracetamol | multiple interactions | ISO | RGD:1313656 | 6480464 | PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of TTK mRNA] | CTD | PMID:17585979 |
| paracetamol | increases expression | ISO | RGD:1313655 | 6480464 | Acetaminophen results in increased expression of TTK mRNA | CTD | PMID:22230336 |
| phenobarbital | increases expression | ISO | RGD:1313656 | 6480464 | Phenobarbital results in increased expression of TTK mRNA | CTD | PMID:23091169 |
| piroxicam | multiple interactions | ISO | RGD:1313655 | 6480464 | Cisplatin promotes the reaction [Piroxicam results in decreased expression of TTK mRNA] | CTD | PMID:21858171 |
| piroxicam | decreases expression | ISO | RGD:1313655 | 6480464 | Piroxicam results in decreased expression of TTK mRNA | CTD | PMID:21858171 |
| quercetin | decreases expression | ISO | RGD:1313655 | 6480464 | Quercetin results in decreased expression of TTK mRNA | CTD | PMID:21632981 |
| resveratrol | decreases expression | ISO | RGD:1313655 | 6480464 | resveratrol results in decreased expression of TTK mRNA | CTD | PMID:15767336 |
| resveratrol | multiple interactions | ISO | RGD:1313655 | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of TTK mRNA | CTD | PMID:19167446 |
| resveratrol | increases expression | ISO | RGD:1313655 | 6480464 | resveratrol results in increased expression of TTK mRNA | CTD | PMID:19167446 |
| sirolimus | multiple interactions | ISO | RGD:1313655 | 6480464 | [fulvestrant co-treated with Sirolimus] results in decreased expression of TTK mRNA | CTD | PMID:19016759 |
| testosterone | multiple interactions | ISO | RGD:1313655 | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of TTK mRNA | CTD | PMID:21592394 |
| testosterone | decreases expression | ISO | RGD:1313655 | 6480464 | Testosterone results in decreased expression of TTK mRNA | CTD | PMID:21592394 |
| tetrachloromethane | affects expression | ISO | RGD:1313656 | 6480464 | Carbon Tetrachloride affects the expression of TTK mRNA | CTD | PMID:17484886 |
| thalidomide | multiple interactions | ISO | RGD:1313655 | 6480464 | [Azacitidine co-treated with Thalidomide] affects the expression of TTK mRNA | CTD | PMID:18720364 |
| thapsigargin | increases expression | ISO | RGD:1313655 | 6480464 | Thapsigargin results in increased expression of TTK mRNA | CTD | PMID:19442820 |
| trans-resveratrol | decreases expression | ISO | RGD:1313655 | 6480464 | resveratrol results in decreased expression of TTK mRNA | CTD | PMID:15767336 |
| trans-resveratrol | multiple interactions | ISO | RGD:1313655 | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of TTK mRNA | CTD | PMID:19167446 |
| trans-resveratrol | increases expression | ISO | RGD:1313655 | 6480464 | resveratrol results in increased expression of TTK mRNA | CTD | PMID:19167446 |
| trimellitic anhydride | increases expression | ISO | RGD:1313656 | 6480464 | trimellitic anhydride results in increased expression of TTK mRNA | CTD | PMID:19042947 |
| troglitazone | decreases expression | ISO | RGD:1313655 | 6480464 | troglitazone results in decreased expression of TTK mRNA | CTD | PMID:19140230 |
| vincaleukoblastine | affects response to substance | ISO | RGD:1313655 | 6480464 | TTK protein affects the susceptibility to Vinblastine | CTD | PMID:16217747 |